The Efficacy and Safety of Herbal Medicine Treatment Strategy for Patients With Post-Accident Fat… (NCT07254169) | Clinical Trial Compass
By InvitationNot Applicable
The Efficacy and Safety of Herbal Medicine Treatment Strategy for Patients With Post-Accident Fatigue
South Korea40 participantsStarted 2026-01
Plain-language summary
This study is a pragmatic randomized controlled pilot clinical trial aimed at evaluating the efficacy and safety of herbal medicine treatment strategy for patients with post-traffic accident fatigue, using an education-only group as the control.
Who can participate
Age range40 Years – 69 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men and women aged 40 to 69 years.
* Patients who have been in a traffic accident for 12 to 24 weeks.
* Patients with an average score of 4 or higher on the FSS-K questionnaire.
* Participants who voluntarily agreed to participate in the study and signed a consent form.
Exclusion Criteria:
* Participants diagnosed with and receiving treatment for a specific disease that may cause fatigue (cancer, anemia, thyroid dysfunction, etc.).
* Participants with clinically significant abnormalities in blood tests that may be a major cause of fatigue.
* Participants taking herbal medicine for fatigue relief or have taken health supplements for fatigue relief within the past two weeks.
* Participants with other chronic conditions that may interfere with the treatment effect or interpretation of results: stroke, myocardial infarction, kidney disease, active hepatitis, diabetic neuropathy, dementia, epilepsy, etc.
* Participants currently taking steroids, immunosuppressants, psychiatric medications, or other medications that may affect the study results.
* Participants who are not suitable for herbal medicine treatment. Unsafe: Patients with conditions that may affect drug intake or absorption, those with digestive problems following surgery related to such conditions, or those with severe liver or kidney disease (AST, ALT, γ-GTP, and serum creatinine levels greater than twice the upper limit of normal during screening).
* Are pregnant, planning to become pregnant, …